Terms: = Leukemia AND PR, PGR, progesterone receptor AND Staging
11 results:
1. Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials.
Chen YT; Valent ET; van Beers EH; Kuiper R; Oliva S; Haferlach T; Chng WJ; van Vliet MH; Sonneveld P; Larocca A
Int J Lab Hematol; 2022 Feb; 44(1):127-134. PubMed ID: 34448362
[TBL] [Abstract] [Full Text] [Related]
2. [Alteration of IFN-γ, IL-4, IL-17 and TGF-β levels in Serum of Patients with Chronic Lymphocytic leukemia Treated with FCR].
Chen LH; Shan KS; Wu PL; Yan ZW; Wang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1615-1620. PubMed ID: 29262885
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical and cytogenetic characteristics of myeloma patients with overall survival less than 24 months].
Zhuang J; Tang W; Li H; Chen M; Han B; Zhu T; Duan M; Li J; Zhang W; Xu Y; Wang S; Zhao Y; Zhou D
Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(10):736-40. PubMed ID: 26080843
[TBL] [Abstract] [Full Text] [Related]
4. A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation.
Sekiguchi Y; Shimada A; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2014; 7(9):6313-22. PubMed ID: 25337285
[TBL] [Abstract] [Full Text] [Related]
5. Cytogenetic and clinical risk factors for assessment of ultra high-risk multiple myeloma.
Zhuang J; Da Y; Li H; Han B; Wan X; Zhu T; Chen M; Duan M; Xu Y; Zhao Y; Shen T; Wua Y; Zhou D
Leuk Res; 2014 Feb; 38(2):188-93. PubMed ID: 24342807
[TBL] [Abstract] [Full Text] [Related]
6. [Analysis of prognostic risk factors in patients with diffuse large B-cell lymphoma].
Yu ZP; Ding JH; Chen BA; Gao C; Wang LL; Chen Z
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):830-5. PubMed ID: 22339956
[TBL] [Abstract] [Full Text] [Related]
7. Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal staging System stage II or III, or extramedullary disease.
Landau H; Pandit-Taskar N; Hassoun H; Cohen A; Lesokhin A; Lendvai N; Drullinsky P; Schulman P; Jhanwar S; Hoover E; Bello C; Riedel E; Nimer SD; Comenzo RL
Leuk Lymphoma; 2012 Feb; 53(2):275-81. PubMed ID: 21824051
[TBL] [Abstract] [Full Text] [Related]
8. Correction of disease related anaemia of B-chronic lymphoproliferative disorders by recombinant human erythropoietin: maintenance is necessary to sustain response.
Siakantaris MP; Angelopoulou MK; Vassilakopoulos TP; Dimopoulou MN; Kontopidou FN; Pangalis GA
Leuk Lymphoma; 2000 Dec; 40(1-2):141-7. PubMed ID: 11426615
[TBL] [Abstract] [Full Text] [Related]
9. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and leukemia Group B phase II study.
Strauss GM; Herndon JE; Sherman DD; Mathisen DJ; Carey RW; Choi NC; Rege VB; Modeas C; Green MR
J Clin Oncol; 1992 Aug; 10(8):1237-44. PubMed ID: 1321893
[TBL] [Abstract] [Full Text] [Related]
10. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia.
Keating MJ
Semin Oncol; 1990 Oct; 17(5 Suppl 8):49-62. PubMed ID: 1699283
[TBL] [Abstract] [Full Text] [Related]
11. Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.
Cheson BD; Bennett JM; Rai KR; Grever MR; Kay NE; Schiffer CA; Oken MM; Keating MJ; Boldt DH; Kempin SJ
Am J Hematol; 1988 Nov; 29(3):152-63. PubMed ID: 3189311
[TBL] [Abstract] [Full Text] [Related]
